Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (19622)	3/11/1999 8:56:00 PM
From: Mkilloran	Read Replies (1) \| Respond to of 23519

vlad...some fun with numbers...next stop $4.07 200 day moving adv 4.07 100 day moving adv 2.77 50 day moving adv 2.68 30 day moving adv 2.63 13 day moving adv 2.86

To: VLAD who wrote (19622)	3/11/1999 9:22:00 PM
From: Silver Knife	Read Replies (1) \| Respond to of 23519

VLAD, Thanks, I have your thead bookmarked. My specialty is cardiology which is frequently where the erectile dysfunction $$ stop. I have come across patients already on MUSE (typically prescribed by urologists), but I have yet to write a prescription for MUSE. Vivus should be marketing the cardiac patients don't qualify or are at a significantly increased risk for viagra. We have a many patients who are bad or borderline candidates for viagra. MUSE has yet to capitalize on this population. Regards, Bernie